Pliant TherapeuticsPLRX
那斯達克 · USD
1.15
+0.02
(+1.32%)
收盤 09/10 03:59 (UTC+8)
09/10 03:59 (UTC+8)
Pliant TherapeuticsPLRX
1.15
+0.02
(+1.32%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 23,862 | 21,772 | 23,577 | 28,269 | 45,592 | - | - | - | - | 52,392 |
研發費用 | 16,727 | 13,584 | 15,585 | 17,938 | 32,198 | 43,436 | 38,793 | 47,754 | 45,617 | 37,146 |
推銷及管理費用 | 7,135 | 8,188 | 7,992 | 10,331 | 13,394 | 15,499 | 14,527 | 14,260 | 15,022 | 15,246 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -23,862 | -21,772 | -23,577 | -28,269 | -45,592 | -58,935 | -53,320 | -62,014 | -60,639 | -52,392 |
其他收入及費用 | - | - | - | - | - | - | - | - | - | - |
利息費用 | - | - | 136 | 815 | 809 | 799 | 834 | 877 | 868 | 445 |
稅前純益 | -22,371 | -20,040 | -23,441 | -25,486 | -42,491 | -55,367 | -48,898 | -56,886 | -54,986 | -46,510 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -22,371 | -20,040 | -23,577 | -26,301 | -43,300 | -56,166 | -49,732 | -57,763 | -55,854 | -46,955 |
基本每股稅後盈餘(元) | -0.36 | -0.32 | -0.38 | -0.43 | -0.71 | -0.92 | -0.82 | -0.95 | -0.92 | -0.78 |
稀釋每股稅後盈餘(元) | -0.37 | -0.32 | -0.38 | -0.43 | -0.70 | -0.92 | -0.81 | -0.95 | -0.93 | -0.78 |
基本平均股數(千股) | 61919.00 | 61803.00 | 61449.00 | 61406.00 | 61386.00 | 61222.00 | 60854.00 | 60730.00 | 60382.00 | 60180.00 |
稀釋平均股數(千股) | 61919.00 | 61803.00 | 61449.00 | 61406.00 | 61386.00 | 61222.00 | 60854.00 | 60730.00 | 60382.00 | 60180.00 |
還原基本每股稅後盈餘(元) | -0.36 | -0.32 | -0.38 | -0.43 | -0.71 | -0.92 | -0.82 | -0.95 | -0.92 | -0.78 |
還原稀釋每股稅後盈餘(元) | -0.37 | -0.32 | -0.38 | -0.43 | -0.70 | -0.92 | -0.81 | -0.95 | -0.93 | -0.78 |
還原基本平均股數(千股) | 61,919 | 61,803 | 61,449 | 61,406 | 61,386 | 61,222 | 60,854 | 60,730 | 60,382 | 60,180 |
還原稀釋平均股數(千股) | 61,919 | 61,803 | 61,449 | 61,406 | 61,386 | 61,222 | 60,854 | 60,730 | 60,382 | 60,180 |
EBITDA(千元) | -22,240 | -19,359 | -22,794 | -24,715 | -40,067 | -53,557 | -47,875 | -55,353 | -54,511 | -44,906 |